CubaseBio
PrivateLast Round
Grant
Feb 17, 2026
Total Funding Raised
$2.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CubaseBio is a biotechnology company that develops tools for 3D spatial analysis at scale, designed to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CubaseBio Comparables
Compare CubaseBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stellaromics | 80% | |
| Resolve Biosciences | 78% | |
| 10X Genomics | 74% |
CubaseBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2026 | ||||
| VC Round | Feb 17, 2026 |
CubaseBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Science Investments | VC Round |
| European Innovation Council Fund | Grant |
| Life Science Invest | VC Round |
| Life Science Invest | Grant |
| Voima Ventures | VC Round |
| Illumina Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
$4.6M round led by Nordic Science Investments and Voima Ventures.
- Feb 17, 2026
Secured $2.37M in grant funding from the European Innovation Council.
Recent news
Latest coverage and updates
- is_developingSep 9, 2026
Cubase Bio AB is developing technologies for cardiovascular drug discovery on Sep 9th '26.
CubaseBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CubaseBio's valuation, stock price, and market status.
Is CubaseBio a public or private company?
CubaseBio is a private company.
What is the current stock price of CubaseBio?
CubaseBio is a private company with no public stock price. No recent secondary market data is available.
How much is CubaseBio worth (valuation)?
Valuation information for CubaseBio is not publicly available.
Can I buy CubaseBio stock?
CubaseBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CubaseBio's last funding round?
CubaseBio's most recent funding round was Grant on February 17, 2026.
Who are the main investors in CubaseBio?
Key investors in CubaseBio include Nordic Science Investments, Voima Ventures.
Will CubaseBio IPO soon?
No public IPO plans have been announced for CubaseBio.
How can I track CubaseBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CubaseBio's secondary market activity and sign up for updates.